Percutaneous Cryoablation of Central Kidney Tumours With Temporary Renal Artery Occlusion

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05461027

Acronym

CP-Renal

Enrollment

Registered

2022-07-15

Start date

2022-05-01

Completion date

2023-12-31

Last updated

2024-12-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Cancer

Keywords

Kidney Cancer, Central Kidney Tumours, Renal Artery Occlusion, cryoablation, Urological surgery, T1a tumours, Cold sink effect, Endovascular balloon clamping, Renal hilum

Brief summary

Percutaneous cryoablation is an alternative to urological surgery for T1a tumours, whose oncological efficacy decreases for the most central tumours due to a cold sink effect.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Adult subject (≥18 years) * Subject who has undergone cryoablation of a central kidney tumour with temporary occlusion of the renal artery by an endovascular balloon at the HUS during the period 01/01/2018 to 30/12/2021 * Subject who has not expressed his/her opposition, after information, to the re-use of his/her data for the purpose of this research.

Exclusion criteria

: * Subject having expressed his/her opposition to participate in the study * Subject under legal protection, guardianship or curatorship

Design outcomes

Primary

Measure	Time frame
Description of the technique of percutaneous cryoablation of central renal tumours with temporary balloon obliteration of the renal artery	Files analysed retrospectively from January 01, 2018 to December 31, 2021 will be examined

Countries

France

Outcome results